Exane Derivatives’s Vanguard Health Care ETF VHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-706
Closed -$180K 980
2022
Q1
$180K Buy
+706
New +$174K 0.05% 361
2021
Q4
Sell
-565
Closed -$140K 1032
2021
Q3
$140K Sell
565
-260
-32% -$66.7K 0.03% 477
2021
Q2
$207K Buy
+825
New +$197K 0.05% 382

Other funds holding VHT

Exane Derivatives's VHT Position: Q2 2022 in Review

Exane Derivatives sold out of Vanguard Health Care ETF (VHT) in Q2 2022, closing a stake of 706 shares — an estimated $180K sold.

Exane Derivatives first reported a position in VHT in Q2 2021 and held it in 3 quarters. The position peaked at $207K in Q2 2021. 877 funds tracked by Wall St. Rank hold VHT as of Q2 2022.

  • Exane Derivatives reported no remaining Vanguard Health Care ETF position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 706 Vanguard Health Care ETF shares in Q2 2022, an estimated $180K.
  • Exane Derivatives first reported a position in Vanguard Health Care ETF in Q2 2021 and held it in 3 quarters.
  • Exane Derivatives's Vanguard Health Care ETF position peaked at $207K in Q2 2021.
  • 877 funds tracked by Wall St. Rank held Vanguard Health Care ETF as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.